Trevor Hay

1.4k total citations · 1 hit paper
21 papers, 882 citations indexed

About

Trevor Hay is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Trevor Hay has authored 21 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Genetics. Recurrent topics in Trevor Hay's work include DNA Repair Mechanisms (7 papers), BRCA gene mutations in cancer (6 papers) and Cancer-related Molecular Pathways (5 papers). Trevor Hay is often cited by papers focused on DNA Repair Mechanisms (7 papers), BRCA gene mutations in cancer (6 papers) and Cancer-related Molecular Pathways (5 papers). Trevor Hay collaborates with scholars based in United Kingdom, Netherlands and Denmark. Trevor Hay's co-authors include David W. Meek, Alan R. Clarke, Owen J. Sansom, David P. Lane, Christine Blattner, John P. Iredale, Thomas G. Bird, Thomas Jamieson, Michael J. Williams and Stuart J. Forbes and has published in prestigious journals such as The Lancet, Nature Cell Biology and Molecular and Cellular Biology.

In The Last Decade

Trevor Hay

19 papers receiving 866 citations

Hit Papers

Hepatic progenitor cells of biliary origin with liver rep... 2015 2026 2018 2022 2015 100 200 300

Peers

Trevor Hay
Amy E. Hanlon Newell United States
Ludovic Ménard United Kingdom
M. Wu China
Sze Hang Lau Hong Kong
Baisong Mei United States
Trevor Hay
Citations per year, relative to Trevor Hay Trevor Hay (= 1×) peers Daniela Gramaglia

Countries citing papers authored by Trevor Hay

Since Specialization
Citations

This map shows the geographic impact of Trevor Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trevor Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trevor Hay more than expected).

Fields of papers citing papers by Trevor Hay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trevor Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trevor Hay. The network helps show where Trevor Hay may publish in the future.

Co-authorship network of co-authors of Trevor Hay

This figure shows the co-authorship network connecting the top 25 collaborators of Trevor Hay. A scholar is included among the top collaborators of Trevor Hay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trevor Hay. Trevor Hay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Williams, Jason S., Cleo Bonnet, Trevor Hay, et al.. (2024). Enhanced bacterial cancer therapy delivering therapeutic RNA interference of c-Myc. Cell & Bioscience. 14(1). 38–38. 4 indexed citations
3.
Tornillo, Giusy, et al.. (2023). NOTCH and AKT Signalling Interact to Drive Mammary Tumour Heterogeneity. Cancers. 15(17). 4324–4324. 2 indexed citations
5.
Hay, Trevor, et al.. (2019). APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression. BMC Cancer. 19(1). 677–677. 23 indexed citations
6.
Hay, Trevor, Robert McEwen, Urszula M. Polanska, et al.. (2019). Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours. Oncotarget. 10(27). 2586–2606. 25 indexed citations
7.
Johnson, C. E., Elaine A. Dunlop, Trevor Hay, et al.. (2018). Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir−bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death. Oncogene. 37(45). 5913–5925. 10 indexed citations
8.
Verma, Vinod Kumar, Tristan D. Clemons, Syed Sultan Beevi, et al.. (2015). RNA Interference Using c-Myc –Conjugated Nanoparticles Suppresses Breast and Colorectal Cancer Models. Molecular Cancer Therapeutics. 14(5). 1259–1269. 27 indexed citations
9.
Lu, Wei‐Yu, Thomas G. Bird, Luke Boulter, et al.. (2015). Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nature Cell Biology. 17(8). 971–983. 345 indexed citations breakdown →
10.
Hay, Trevor, James R. Matthews, Alan Lau, et al.. (2009). Poly(ADP-Ribose) Polymerase-1 Inhibitor Treatment Regresses Autochthonous Brca2/p53 -Mutant Mammary Tumors In vivo and Delays Tumor Relapse in Combination with Carboplatin. Cancer Research. 69(9). 3850–3855. 94 indexed citations
11.
Hay, Trevor, James R. Matthews, Alan Lau, et al.. (2008). PARP-1 inhibitor monotherapy and combination therapy in a preclinical mouse model of Brca2 mutant breast cancer. Breast Cancer Research. 10(S2). 4 indexed citations
12.
Méniel, Valérie S., Trevor Hay, Anthony Douglas-Jones, Owen J. Sansom, & Alan R. Clarke. (2005). Mutations in Apc and p53 Synergize to Promote Mammary Neoplasia. Cancer Research. 65(2). 410–416. 14 indexed citations
14.
Hay, Trevor & Alan R. Clarke. (2005). DNA damage hypersensitivity in cells lacking BRCA2: a review of in vitro and in vivo data. Biochemical Society Transactions. 33(4). 715–717. 5 indexed citations
15.
Hay, Trevor, Helen Jenkins, Owen J. Sansom, et al.. (2005). Efficient Deletion of Normal Brca2-Deficient Intestinal Epithelium by Poly(ADP-Ribose) Polymerase Inhibition Models Potential Prophylactic Therapy. Cancer Research. 65(22). 10145–10148. 51 indexed citations
16.
Gallagher, Ronald, Trevor Hay, Valérie S. Méniel, et al.. (2002). Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency. Oncogene. 21(42). 6446–6457. 31 indexed citations
17.
Blattner, Christine, Trevor Hay, David W. Meek, & David P. Lane. (2002). Hypophosphorylation of Mdm2 Augments p53 Stability. Molecular and Cellular Biology. 22(17). 6170–6182. 118 indexed citations
18.
Hjerrild, Majbrit, Diane Milne, Nicolas Dumaz, et al.. (2001). Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells. Biochemical Journal. 355(2). 347–347. 35 indexed citations
19.
Hjerrild, Majbrit, Diane Milne, Nicolas Dumaz, et al.. (2001). Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells. Biochemical Journal. 355(2). 347–356. 22 indexed citations
20.
Hay, Trevor & David W. Meek. (2000). Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains. FEBS Letters. 478(1-2). 183–186. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026